Table 4.
Baseline demographic and clinical characteristics of propensity-matched cohort
| Induction + Transabdominal resection | Induction + Local excision | p-value | |
|---|---|---|---|
| (n=639) | (n=639) | ||
| Age, years (mean, STD) | 64 (16) | 64 (14.5) | 0.775 |
| Gender (female) | 36.3% (232) | 35.8% (229) | 0.907 |
| Race | 0.937 | ||
| White | 90.8% (580) | 90.3% (577) | |
| Black | 5.5% (35) | 5.9% (38) | |
| Other | 3.8% (24) | 3.8% (24) | |
| Year of diagnosis, median (IQR) | 2010 (4) | 2010 (4) | 0.785 |
| Charleson-Deyo Comorbidity Index | 0.869 | ||
| 0 | 82.6% (528) | 81.8% (523) | |
| 1 | 12.7% (81) | 12.8% (82) | |
| 2+ | 4.7% (30) | 5.3% (34) | |
| Insurance status | 0.978 | ||
| Private | 48.0% (307) | 48.2% (308) | |
| Government | 49.9% (319) | 49.6% (317) | |
| None | 2.0% (13) | 2.2% (14) | |
| Facility location | 0.923 | ||
| Metro | 77.0% (492) | 77.2% (493) | |
| Urban | 20.7% (132) | 20.2% (129) | |
| Rural | 2.3% (15) | 2.7% (17) | |
| Academic/Research Program | 24.7% (158) | 25.2% (161) | 0.897 |
| Adjuvant therapy | 0.337 | ||
| None | 80.6% (515) | 83.6% (534) | |
| Radiation | 0.2% (1) | 0.5% (3) | |
| Chemotherapy | 18.6% (119) | 15.3% (98) | |
| Chemoradiation | 0.6% (4) | 0.6% (4) |
IQR, interquartile range